5 Easy Facts About Is ABBV-744 effective for hematologic cancers? Described
The existing work examined the potential of employing ARV-825 and ABBV-744 to boost the effectiveness of tamoxifen or fulvestrant as well as palbociclib. ARV-825 was effective in both equally p53 wild-type (WT) breast tumor cells and in cells lacking functional p53 either alone or in combination with tamoxifen, when the effectiveness of ABBV-744 wa